Lode J. Swinnen - Concepedia

Author

Lode J. Swinnen

Johns Hopkins University

Also Known As

Erik M van Maarseveen, L J Swinnen, L Swinnen, Lode J Swinnen, Lode J. Swinnen, Lode Swinnen

193

Publications

10.3K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Loyola University Chicago Johns Hopkins Medicine Memorial Sloan Kettering Cancer Center

About

Lode J. Swinnen is an author at Johns Hopkins University specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	43	4.1K
2	Health Sciences	8	8	1.2K
3	Blood Transplantation	8	8	1.6K
4	Natural Sciences	1	1	10
5	Biochemistry	1	1	10

Lode J. Swinnen

104

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients Lode J. Swinnen, Maria Rosa Costanzo‐Nordin, Susan G. Fisher, New England Journal of Medicine Heart FailureImmunologyPathologyImmunotherapyCardiac-transplant Recipients	1990	949
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementHigh-grade GliomasBrain LesionGlioma	2020	538
Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis Michael Glantz, Suzanne LaFollette, Kurt A. Jaeckle, Journal of Clinical Oncology	1999	398
Non-Hodgkin’s Lymphomas Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, Journal of the National Comprehensive Cancer Network	2010	328
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Blood	2015	297
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1 Wida S. Cherikh, H. Myron Kauffman, Maureen McBride, Transplantation	2003	296
Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome Yvette L. Kasamon, Leo Luznik, Mary S. Leffell, Biology of Blood and Marrow Transplantation	2009	278
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults Yvette L. Kasamon, Javier Bolaños‐Meade, Gabrielle T. Prince, Journal of Clinical Oncology	2015	237
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017 Burt Nabors, Jana Portnow, Mario Ammirati, Journal of the National Comprehensive Cancer Network Neuro-oncologyTumor BiologyGlioma ProgressionMalignant DiseaseMolecular Markers	2017	229
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022 Craig Horbinski, Burt Nabors, Jana Portnow, Journal of the National Comprehensive Cancer Network	2023	197

Page 1